• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受放疗和雄激素剥夺治疗的前列腺癌男性患者疲劳的评估及预测因素

Assessment and predictors of fatigue in men with prostate cancer receiving radiotherapy and androgen deprivation therapy.

作者信息

Bandara Vindya, Capp Anne, Ahmed Gias, Arm Jameen, Martin Jarad

机构信息

Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia.

School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.

出版信息

J Med Imaging Radiat Oncol. 2019 Oct;63(5):683-690. doi: 10.1111/1754-9485.12922. Epub 2019 Jul 10.

DOI:10.1111/1754-9485.12922
PMID:31588674
Abstract

INTRODUCTION

Fatigue is a commonly reported symptom in men receiving radiation therapy and androgen deprivation therapy (ADT) for prostate cancer. Despite this, the complex mechanisms remain unclear. This study aims to investigate factors which correlate with development of fatigue.

METHODS

Twenty-seven men with high-risk prostate cancer undergoing radiation therapy and 18 months of ADT were assessed for fatigue, haemoglobin (Hb), testosterone, magnetic resonance imaging (MRI) fat fraction (FF) and apparent diffusion coefficient (ADC), at baseline and at intervals after radiotherapy. Changes from baseline were analysed using paired t-tests. Linear time trends were assessed using linear mixed effect models.

RESULTS

Overall, mean fatigue score increased from baseline to the 18-month time interval (difference 4.5, P = 0.0114). The mean value for Hb significantly decreased (P < 0.001) from baseline to 18 months. The mean value for testosterone significantly decreased (P < 0.001) from baseline to 12 months, and remained low. Mean for MRI FF showed a significant increase (P < 0.001) from baseline to 6 months. MRI ADC showed a non-significant decrease from baseline to 6 months (P = 0.4416).

CONCLUSION

Radiotherapy and ADT resulted in a significant increase in fatigue scores. Statistically significant changes were noted in Hb, testosterone and MRI FF and ADC, however, none were shown to have a strong association with worsening fatigue. Further investigation in a larger cohort is required to assess the interaction between fatigue and possible biological factors.

摘要

引言

疲劳是接受前列腺癌放射治疗和雄激素剥夺疗法(ADT)的男性中常见的症状。尽管如此,其复杂机制仍不清楚。本研究旨在调查与疲劳发展相关的因素。

方法

对27例接受放射治疗和18个月ADT的高危前列腺癌男性患者在基线时以及放疗后的不同时间间隔进行疲劳、血红蛋白(Hb)、睾酮、磁共振成像(MRI)脂肪分数(FF)和表观扩散系数(ADC)评估。使用配对t检验分析与基线的变化。使用线性混合效应模型评估线性时间趋势。

结果

总体而言,平均疲劳评分从基线到18个月时间间隔有所增加(差值4.5,P = 0.0114)。Hb的平均值从基线到18个月显著下降(P < 0.001)。睾酮的平均值从基线到12个月显著下降(P < 0.001),并保持在低水平。MRI FF的平均值从基线到6个月显著增加(P < 0.001)。MRI ADC从基线到6个月呈非显著下降(P = 0.4416)。

结论

放疗和ADT导致疲劳评分显著增加。在Hb、睾酮以及MRI FF和ADC方面观察到有统计学意义的变化,然而,没有一个被证明与疲劳加重有强烈关联。需要在更大的队列中进行进一步研究,以评估疲劳与可能的生物学因素之间的相互作用。

相似文献

1
Assessment and predictors of fatigue in men with prostate cancer receiving radiotherapy and androgen deprivation therapy.接受放疗和雄激素剥夺治疗的前列腺癌男性患者疲劳的评估及预测因素
J Med Imaging Radiat Oncol. 2019 Oct;63(5):683-690. doi: 10.1111/1754-9485.12922. Epub 2019 Jul 10.
2
Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity.接受雄激素剥夺治疗的前列腺癌男性患者中,脊柱多参数磁共振成像(MRI)和双能X线吸收法(DEXA)随时间的变化:一种潜在的治疗毒性影像生物标志物
Eur Radiol. 2017 Mar;27(3):995-1003. doi: 10.1007/s00330-016-4434-z. Epub 2016 Jun 10.
3
The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.接受剂量递增外照射放疗的中危前列腺癌患者雄激素剥夺治疗的必要性。
Can J Urol. 2017 Feb;24(1):8656-8662.
4
Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.接受雄激素剥夺治疗的前列腺癌男性患者疲劳的特征及预测因素:一项对照比较研究
Support Care Cancer. 2016 Oct;24(10):4159-66. doi: 10.1007/s00520-016-3241-z. Epub 2016 May 3.
5
High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy.采用低剂量率近距离放射治疗联合或不联合雄激素剥夺治疗的中高危前列腺癌。
Brachytherapy. 2017 Nov-Dec;16(6):1101-1105. doi: 10.1016/j.brachy.2017.08.003. Epub 2017 Oct 12.
6
Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.雄激素剥夺治疗时间与运动适应性:一项针对前列腺癌男性患者的12个月随机对照试验的二次分析
BJU Int. 2018 Feb;121(2):194-202. doi: 10.1111/bju.14008. Epub 2017 Sep 22.
7
Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer.雄激素剥夺治疗 1 年内血红蛋白浓度变化对激素初治骨转移前列腺癌的临床和预后意义。
BJU Int. 2018 Oct;122(4):583-591. doi: 10.1111/bju.14227. Epub 2018 May 30.
8
Quality of life in prostate cancer patients taking androgen deprivation therapy.接受雄激素剥夺治疗的前列腺癌患者的生活质量。
J Am Geriatr Soc. 2006 Jan;54(1):85-90. doi: 10.1111/j.1532-5415.2005.00567.x.
9
Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer.扩散加权成像评估前列腺癌去势治疗后的变化。
AJR Am J Roentgenol. 2014 Dec;203(6):W645-50. doi: 10.2214/AJR.13.12277.
10
Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.雄激素剥夺疗法对前列腺癌男性疼痛感知、生活质量和抑郁的影响。
J Pain Symptom Manage. 2018 Feb;55(2):307-317.e1. doi: 10.1016/j.jpainsymman.2017.09.017. Epub 2017 Sep 21.

引用本文的文献

1
Actors influencing cancer-related fatigue and the construction of a risk prediction model in lung cancer patients.影响肺癌患者癌症相关疲劳的因素及风险预测模型的构建
Front Oncol. 2025 Jan 24;14:1485317. doi: 10.3389/fonc.2024.1485317. eCollection 2024.
2
Androgen Signaling in Prostate Cancer: When a Friend Turns Foe.前列腺癌中的雄激素信号传导:当朋友变成敌人时。
Endocr Metab Immune Disord Drug Targets. 2025;25(1):37-56. doi: 10.2174/0118715303313528240523101940.
3
Adipocyte-Cancer Cell Interactions in the Bone Microenvironment.
脂肪细胞-癌细胞在骨微环境中的相互作用。
Front Endocrinol (Lausanne). 2022 Jul 12;13:903925. doi: 10.3389/fendo.2022.903925. eCollection 2022.
4
Fatigue prevalence in men treated for prostate cancer: A systematic review and meta-analysis.前列腺癌治疗男性的疲劳患病率:一项系统评价和荟萃分析。
World J Clin Cases. 2021 Jul 26;9(21):5932-5942. doi: 10.12998/wjcc.v9.i21.5932.
5
A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer.恩杂鲁胺治疗后临床结局与通过液相色谱-串联质谱法测定的去势抵抗性前列腺癌患者血清雄激素水平之间关系的前瞻性研究。
Eur Urol Open Sci. 2021 Jun 7;29:59-67. doi: 10.1016/j.euros.2021.05.003. eCollection 2021 Jul.
6
Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers.将患者报告结局纳入泌尿生殖系统癌症药物研发中。
Curr Oncol Rep. 2020 Feb 8;22(3):21. doi: 10.1007/s11912-020-0890-3.